Literature DB >> 9647169

Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy.

A V Kulkarni1, A Guha, A Lozano, M Bernstein.   

Abstract

OBJECT: Many neurosurgeons routinely obtain computerized tomography (CT) scans to rule out hemorrhage in patients after stereotactic procedures. In the present prospective study, the authors investigated the rate of silent hemorrhage and delayed deterioration after stereotactic biopsy sampling and the role of postbiopsy CT scanning.
METHODS: A subset of patients (the last 102 of approximately 800 patients) who underwent stereotactic brain biopsies at the Toronto Hospital prospectively underwent routine postoperative CT scanning within hours of the biopsy procedure. Their medical charts and CT scans were then reviewed. A postoperative CT scan was obtained in 102 patients (aged 17-87 years) who underwent stereotactic biopsy between June 1994 and September 1996. Sixty-one patients (59.8%) exhibited hemorrhages, mostly intracerebral (54.9%), on the immediate postoperative scan. Only six of these patients were clinically suspected to have suffered a hemorrhage based on immediate postoperative neurological deficit: in the remaining 55 (53.9%) of 102 patients, the hemorrhage was clinically silent and unsuspected. Among the clinically silent intracerebral hemorrhages, 22 measured less than 5 mm. 20 between 5 and 10 mm, five between 10 and 30 mm, and four between 30 and 40 mm. Of the 55 patients with clinically silent hemorrhages, only three demonstrated a delayed neurological deficit (one case of seizure and two cases of progressive loss of consciousness) and these all occurred within the first 2 postoperative days. Of the neurologically well patients in whom no hemorrhage was demonstrated on initial postoperative CT scan, none experienced delayed deterioration.
CONCLUSIONS: Clinically silent hemorrhage after stereotactic biopsy is very common. However, the authors did not find that knowledge of its existence ultimately affected individual patient management or outcome. The authors, therefore, suggest that the most important role of postoperative CT scanning is to screen for those neurologically well patients with no hemorrhage. These patients could safely be discharged on the same day they underwent biopsy.

Entities:  

Mesh:

Year:  1998        PMID: 9647169     DOI: 10.3171/jns.1998.89.1.0031

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  28 in total

1.  Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies.

Authors:  Georg Widhalm; Georgi Minchev; Adelheid Woehrer; Matthias Preusser; Barbara Kiesel; Julia Furtner; Aygül Mert; Antonio Di Ieva; Boguslaw Tomanek; Daniela Prayer; Christine Marosi; Johannes A Hainfellner; Engelbert Knosp; Stefan Wolfsberger
Journal:  Neurosurg Rev       Date:  2012-03-10       Impact factor: 3.042

Review 2.  Biology and treatment of primary central nervous system lymphoma.

Authors:  Alain P Algazi; Cigall Kadoch; James L Rubenstein
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

3.  Effect of Perfusion on Diffusion Kurtosis Imaging Estimates for In Vivo Assessment of Integrated 2016 WHO Glioma Grades : A Cross-Sectional Observational Study.

Authors:  Johann-Martin Hempel; Jens Schittenhelm; Cornelia Brendle; Benjamin Bender; Georg Bier; Marco Skardelly; Ghazaleh Tabatabai; Salvador Castaneda Vega; Ulrike Ernemann; Uwe Klose
Journal:  Clin Neuroradiol       Date:  2017-07-12       Impact factor: 3.649

4.  Interstitial imaging with multiple diffusive reflectance spectroscopy projections for in vivo blood vessels detection during brain needle biopsy procedures.

Authors:  Fabien Picot; Andréanne Goyette; Sami Obaid; Joannie Desroches; Simon Lessard; Marie-André Tremblay; Mathias Strupler; Brian Wilson; Kevin Petrecca; Gilles Soulez; Frédéric Leblond
Journal:  Neurophotonics       Date:  2019-04-23       Impact factor: 3.593

5.  Use of intra-operative stimulation of brainstem lesion target sites for frameless stereotactic biopsies.

Authors:  Jason Labuschagne; Denis Mutyaba; Jacques Nel; Claudia Casieri
Journal:  Childs Nerv Syst       Date:  2021-03-08       Impact factor: 1.475

6.  Institutional charges and disparities in outpatient brain biopsies in four US States: the State Ambulatory Database (SASD).

Authors:  Kimon Bekelis; Symeon Missios; David W Roberts
Journal:  J Neurooncol       Date:  2013-11       Impact factor: 4.130

7.  Ocular involvement in patients with primary CNS lymphoma.

Authors:  Jung Taeck Hong; Ju Byung Chae; Joo Yong Lee; June-Gone Kim; Young Hee Yoon
Journal:  J Neurooncol       Date:  2010-07-24       Impact factor: 4.130

8.  In vivo molecular profiling of human glioma using diffusion kurtosis imaging.

Authors:  Johann-Martin Hempel; Sotirios Bisdas; Jens Schittenhelm; Cornelia Brendle; Benjamin Bender; Henk Wassmann; Marco Skardelly; Ghazaleh Tabatabai; Salvador Castaneda Vega; Ulrike Ernemann; Uwe Klose
Journal:  J Neurooncol       Date:  2016-09-07       Impact factor: 4.130

9.  Postoperative management of patients after stereotactic biopsy: results of a survey of the AANS/CNS section on tumors and a single institution study.

Authors:  Ronald E Warnick; Lynn M Longmore; Christian A Paul; Laurie A Bode
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

10.  Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.

Authors:  S A Grimm; C A McCannel; A M P Omuro; A J M Ferreri; J-Y Blay; E A Neuwelt; T Siegal; T Batchelor; K Jahnke; T N Shenkier; A J Hall; F Graus; U Herrlinger; D Schiff; J Raizer; J Rubenstein; N Laperriere; E Thiel; N Doolittle; F M Iwamoto; L E Abrey
Journal:  Neurology       Date:  2008-10-21       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.